The Role of CYP8B1 Polymorphisms in Modulating the Biochemical Pathways Affected by SGLT2 Inhibitors in T2DM and Obesity

Clinical trial NCT07120828 · COMPLETED

Trial details

NCT number: NCT07120828
Sponsor: Erbil Polytechnic University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Obese Diabetics Obese Patients (BMI ≥ 30 kg/m²)

Start date: 2025-07-15
Primary completion: 2025-08-30
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.